CDH1 and prostate carcinoma: E-Cadherin was also reduced in DU145/XB130- and LNCap/XB130- associated with enhancement of vimentin expression, indicated that XB130 may promote migration and invasion of prostate cancer through mediating EMT by activating PI3K/Akt.